Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, announces that its Chief Scientific Officer, Henri ...
The MarketWatch News Department was not involved in the creation of this content. -- NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in ...
Results demonstrated early signals of C-peptide preservationT1D key opinion leader, Michael J. Haller, MD, provided a ...
The MarketWatch News Department was not involved in the creation of this content.-- Cebranopadol is an investigational first-of-its kind dual NOP/MOP receptor (NMR) agonist which ...
Abstract: Part II investigates phase modulation as a low-complexity alternative to conventional phase shifters in pattern-reconfigurable antenna arrays. In the proposed architecture, phase formation ...
Researchers have made a major advance in quantum computing with a new device that is nearly 100 times smaller than the diameter of a human hair. Published in the journal Nature Communications, the ...
Doing more with less in electronics often means improving power density. One of the new areas garnering attention involves applying a variety of advanced modulation techniques, including PWM and space ...
Abstract: Ground moving target indication (GMTI) in the synthetic aperture radar (SAR) system enables high-resolution, all-weather, and all-day imaging and detection of moving targets, posing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results